Compile Data Set for Download or QSAR
maximum 50k data
Found 52 Enz. Inhib. hit(s) with all data for entry = 2968
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291359((E)-3-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3...)
Affinity DataIC50:  5nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291363(2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-morpholin-4-y...)
Affinity DataIC50:  6nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291360(US9580442, Example H | US9938290, H | [2-(1H-Indol...)
Affinity DataIC50:  6nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM387173(US9938290, F)
Affinity DataIC50:  6nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291355(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  6nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291357(2,8-Bis-(1H-indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  7nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291365(2-(1H-Indol-4-yl)-4,8-di-morpholin-4-yl-pyrido[3&#...)
Affinity DataIC50:  10nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291361(2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-piperidin-1-y...)
Affinity DataIC50:  10nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  15nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291355(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  19nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291364(US9580442, Example L | US9938290, L | [2-(1H-Indol...)
Affinity DataIC50:  21nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291366(3-{4-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  22nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291365(2-(1H-Indol-4-yl)-4,8-di-morpholin-4-yl-pyrido[3&#...)
Affinity DataIC50:  25nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291362(2-(1H-Indol-4-yl)-8-(4-methyl-piperazin-1-ylmethyl...)
Affinity DataIC50:  26nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291356(4-Morpholin-4-yl-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)...)
Affinity DataIC50:  33nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  54nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291356(4-Morpholin-4-yl-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)...)
Affinity DataIC50:  57nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291360(US9580442, Example H | US9938290, H | [2-(1H-Indol...)
Affinity DataIC50:  63nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291363(2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-morpholin-4-y...)
Affinity DataIC50:  64nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291357(2,8-Bis-(1H-indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  69nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291359((E)-3-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3...)
Affinity DataIC50:  83nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291357(2,8-Bis-(1H-indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  88nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291365(2-(1H-Indol-4-yl)-4,8-di-morpholin-4-yl-pyrido[3&#...)
Affinity DataIC50:  96nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291356(4-Morpholin-4-yl-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)...)
Affinity DataIC50:  103nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291356(4-Morpholin-4-yl-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)...)
Affinity DataIC50:  104nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM387173(US9938290, F)
Affinity DataIC50:  109nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291364(US9580442, Example L | US9938290, L | [2-(1H-Indol...)
Affinity DataIC50:  111nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM387173(US9938290, F)
Affinity DataIC50:  127nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291366(3-{4-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  131nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  137nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291355(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  159nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291360(US9580442, Example H | US9938290, H | [2-(1H-Indol...)
Affinity DataIC50:  213nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291365(2-(1H-Indol-4-yl)-4,8-di-morpholin-4-yl-pyrido[3&#...)
Affinity DataIC50:  219nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291359((E)-3-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3...)
Affinity DataIC50:  223nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM387173(US9938290, F)
Affinity DataIC50:  269nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291362(2-(1H-Indol-4-yl)-8-(4-methyl-piperazin-1-ylmethyl...)
Affinity DataIC50:  277nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291355(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  317nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291363(2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-morpholin-4-y...)
Affinity DataIC50:  355nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291360(US9580442, Example H | US9938290, H | [2-(1H-Indol...)
Affinity DataIC50:  398nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291361(2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-piperidin-1-y...)
Affinity DataIC50:  503nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291361(2-(1H-Indol-4-yl)-4-morpholin-4-yl-8-piperidin-1-y...)
Affinity DataIC50:  508nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291366(3-{4-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  597nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291364(US9580442, Example L | US9938290, L | [2-(1H-Indol...)
Affinity DataIC50:  604nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291357(2,8-Bis-(1H-indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  627nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291362(2-(1H-Indol-4-yl)-8-(4-methyl-piperazin-1-ylmethyl...)
Affinity DataIC50:  680nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  873nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291362(2-(1H-Indol-4-yl)-8-(4-methyl-piperazin-1-ylmethyl...)
Affinity DataIC50:  1.04E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291359((E)-3-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3...)
Affinity DataIC50:  1.66E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291364(US9580442, Example L | US9938290, L | [2-(1H-Indol...)
Affinity DataIC50:  1.82E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291366(3-{4-[2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3&...)
Affinity DataIC50:  2.54E+3nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: